Development of a clinical diagnostic tool to differentiate multiple myeloma from bone metastasis in patients with destructive bone lesions (MM-BM DDx)

被引：0
|
作者：
Phichayut Phinyo
Titinat Maihom
Areerak Phanphaisarn
Pakorn Kerdsinchai
Ekarat Rattarittamrong
Jayanton Patumanond
Dumnoensun Pruksakorn
机构：
[1] Chiang Mai University,Department of Family Medicine, Faculty of Medicine
[2] Chiang Mai University,Center for Clinical Epidemiology and Clinical Statistics, Faculty of Medicine
[3] Chiang Mai University,Musculoskeletal Science and Translational Research (MSTR)
[4] Chiang Mai University,Department of Internal Medicine, Faculty of Medicine, Division of hematology
[5] Chiang Mai University,Biomedical Engineering Institute
[6] Chiang Mai University,Omics Center for Health Sciences (OCHS), Faculty of Medicine
[7] Chiang Mai University,Department of Orthopedics, Faculty of Medicine, Orthopedic Laboratory and Research Network (OLARN)
来源：
BMC Family Practice | / 21卷
关键词：
Bone metastasis; Diagnosis; Multiple myeloma; Osteolytic lesion; Prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Development of a clinical diagnostic tool to differentiate multiple myeloma from bone metastasis in patients with destructive bone lesions (MM-BM DDx)
    Phinyo, Phichayut
    Maihom, Titinat
    Phanphaisarn, Areerak
    Kerdsinchai, Pakorn
    Rattarittamrong, Ekarat
    Patumanond, Jayanton
    Pruksakorn, Dumnoensun
    BMC FAMILY PRACTICE, 2020, 21 (01)
  • [2] Correction: Development of a clinical diagnostic tool to differentiate multiple myeloma from bone metastasis in patients with destructive bone lesions (MM-BM DDx)
    Phichayut Phinyo
    Titinat Maihom
    Areerak Phanphaisarn
    Pakorn Kerdsinchai
    Ekarat Rattarittamrong
    Jayanton Patumanond
    Dumnoensun Pruksakorn
    BMC Primary Care, 23
  • [3] Development of a clinical diagnostic tool to differentiate multiple myeloma from bone metastasis in patients with destructive bone lesions (MM-BM DDx) (vol 21, 215, 2020)
    Phinyo, Phichayut
    Maihom, Titinat
    Phanphaisarn, Areerak
    Kerdsinchai, Pakorn
    Rattarittamrong, Ekarat
    Patumanond, Jayanton
    Pruksakorn, Dumnoensun
    BMC PRIMARY CARE, 2022, 23 (01):
  • [4] Validation of a Diagnostic Model to Differentiate Multiple Myeloma from Bone Metastasis
    Phinyo, Phichayut
    Jarupanich, Nutcha
    Lumkul, Lalita
    Phanphaisarn, Areerak
    Poosiripinyo, Thanate
    Sukpanichyingyong, Sermsak
    Thanindratarn, Pichaya
    Pornmeechai, Yodsawee
    Wisanuyotin, Taweechok
    Phimolsarnti, Rapin
    Rattarittamrong, Ekarat
    Pruksakorn, Dumnoensun
    CLINICAL EPIDEMIOLOGY, 2023, 15 : 881 - 890
  • [5] Prognostic significance of biochemical markers of bone metabolism in patients with bone lesions from multiple myeloma (MM).
    Cook, RJ
    Coleman, RE
    Major, P
    Lipton, A
    Brown, JE
    Lee, KA
    Smith, M
    Saad, F
    Chen, YM
    Hei, YJ
    BLOOD, 2005, 106 (11) : 335B - 335B
  • [6] A retrospective database analysis of treatment pattern and outcomes for multiple myeloma (MM) patients with malignant bone lesions (BM)
    Spencer, D.
    Perez-Torrealba, J. R.
    Kaura, S.
    Henk, H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Role of FDG PET/CT in the history of multiple myeloma (MM) patients with bone lesions at diagnosis
    Nanni, Cristina
    Zamagni, Elena
    Castellucci, Palo
    Montini, Gian Carlo
    Ambrosini, Valentina
    Pettinato, Vincenzina
    Boschi, Stefano
    Rubello, Domenico
    Fanti, Stefano
    Grassetto, Gaia
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [8] Determining the extent of disease with magnetic resonance imaging of the bone marrow (BM-MRI) in patients with multiple myeloma (MM)
    Ailawadhi, Sikander
    Derby, Lyudmyla
    Mashtare, Terry L.
    Miller, Kena C.
    Wilding, Gregory
    Padmanabhan, Swaminathan
    Gottlieb, Ronald
    Alberico, Ronald A.
    Klippenstein, Donald L.
    Abdelhalim, Ahmed N.
    Chanan-Khan, Asher A.
    BLOOD, 2007, 110 (11) : 444A - 444A
  • [9] Improved sensitivity of Bone Marrow Magnetic Resonance Imaging (BM-MRI) in quantifying the extent of bone marrow involvement in patients with Multiple Myeloma (MM)
    Ailawadhi, Sikander
    Derby, Lyudmyla
    Miller, Kena C.
    Mashtare, Terry L.
    Wilding, Gregory
    Padmanabhan, Swaminathan
    Gottlieb, Ronald
    Alberico, Ronald A.
    Klippenstein, Donald L.
    Abdelhalim, Ahmed N.
    Chanan-Khan, Asher A.
    BLOOD, 2007, 110 (11) : 267B - 267B
  • [10] Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM)
    Ippolito, Davide
    Besostri, Valeria
    Bonaffini, Pietro Andrea
    Rossini, Fausto
    Di Lelio, Alessandro
    Sironi, Sandro
    EUROPEAN JOURNAL OF RADIOLOGY, 2013, 82 (12) : 2322 - 2327
12345